STATE STREET CORP - BENITEC BIOPHARMA INC ownership

BENITEC BIOPHARMA INC's ticker is BNTC and the CUSIP is 08205P100. A total of 19 filers reported holding BENITEC BIOPHARMA INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of BENITEC BIOPHARMA INC
ValueSharesWeighting
Q2 2023$5,113
+13.6%
21,4380.0%0.00%
Q1 2023$4,500
-38.3%
21,438
-50.0%
0.00%
Q4 2022$7,288
-8.9%
42,876
+100.0%
0.00%
Q3 2022$8,000
-68.0%
21,4380.0%0.00%
Q2 2022$25,000
-50.0%
21,4380.0%0.00%
Q1 2022$50,000
-9.1%
21,438
+2.1%
0.00%
Q4 2021$55,000
-26.7%
21,0000.0%0.00%
Q3 2021$75,000
-15.7%
21,0000.0%0.00%
Q2 2021$89,00021,0000.00%
Other shareholders
BENITEC BIOPHARMA INC shareholders Q2 2021
NameSharesValueWeighting ↓
SUVRETTA CAPITAL MANAGEMENT, LLC 769,000$130,7300.01%
Virtu Financial LLC 80,867$140.00%
FRANKLIN RESOURCES INC 10,000,000$1,700,0000.00%
Walleye Capital LLC 344,015$58,4830.00%
WealthTrust Axiom LLC 12,950$2,2020.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
UBS Group AG 1,274$2170.00%
Rockefeller Capital Management L.P. 300$00.00%
TWO SIGMA INVESTMENTS, LP 28,953$4,9220.00%
Rosenberg Matthew Hamilton 381$650.00%
View complete list of BENITEC BIOPHARMA INC shareholders